StockData
Panacea Life Sciences Holdings, Inc. logo

Panacea Life Sciences Holdings, Inc. (PLSH) stock

PLSHOTCMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
Financials through Q1 FY2024, quarter ended Mar 31, 2024Last filing: 10-Q on May 6, 2024
$0.07+0.00 (+5.45%)

Close on Oct 19, 2026Market cap $1.15MP/E –Yield –

Panacea Life Sciences total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

Panacea Life Sciences's total debt was $125.69K at Mar 31, 2021. For fiscal 2020 it was $901.45K, up 384.9% from the year before.

Annual total debt

PeriodPeriod endValueChange
FY2020Dec 31, 2020$901.45K+384.9%
FY2019Dec 31, 2019$185.91K-62.2%
FY2018Dec 31, 2018$491.79K–
FY2017Dec 31, 2017$0–

Quarterly total debt

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q1 FY2021Mar 31, 2021$125.69K-32.4%
Q4 FY2020Dec 31, 2020$901.45K+83.3%
Q3 FY2020Sep 30, 2020$205.17K–
Q2 FY2020Jun 30, 2020$244.76K–
Q4 FY2019Dec 31, 2019$185.91K–
Q4 FY2018Dec 31, 2018$491.79K–
Q4 FY2017Dec 31, 2017$0–

More Panacea Life Sciences figures

See a number that looks wrong?